Is Sharpe Strumia Research Foundation Of The Bryn Mawr Hospital Legit?

The Sharpe Strumia Research Foundation of The Bryn Mawr Hospital demonstrates consistent financial health with a strong asset base, currently at $24,560,991. Over the past decade, the organization has shown steady growth in assets, indicating effective financial management and investment strategies. Its revenue streams have fluctuated, with the latest reported revenue at $1,633,377, but expenses have generally remained well below revenue, leading to consistent surpluses. The foundation's commitment to its mission is evident through its program spending, which appears to be the primary allocation of its resources, aligning with its NTEE code for medical research. The absence of officer compensation reported across all available filings suggests a highly efficient use of funds, potentially relying on volunteer leadership or compensation being covered by the affiliated hospital, which enhances its spending efficiency. Regarding transparency, the organization has a robust filing history with 13 IRS 990 filings, indicating consistent compliance with regulatory requirements. The detailed financial data available through these filings allows for a clear understanding of its financial operations. The consistent reporting of zero officer compensation is a significant positive indicator of financial stewardship and a focus on directing resources towards its research mission rather than executive salaries. This level of transparency in compensation practices is commendable and builds trust with potential donors and the public. Overall, the Sharpe Strumia Research Foundation appears to be a financially sound and efficiently managed organization. Its substantial and growing asset base provides long-term stability, while its spending patterns suggest a strong dedication to its programmatic goals. The consistent reporting and lack of executive compensation further bolster its image as a transparent and responsible steward of charitable funds, making it an attractive entity for those looking to support medical research.